Coronavirus channel feed

Tur­moil at CBER: Pe­ter Marks grabs con­trol of FDA's Of­fice of Vac­cines ahead of 2 key ca­reer leader de­par­tures

4 years ago
FDA+

Opin­ion: How the con­fus­ing boost­er shot de­ba­cle aligns Biden with Trump's pan­dem­ic re­sponse

4 years ago
Opinion

Covid-19 roundup: Nor­mal life is in sight, but not with­out fur­ther vac­ci­na­tions — Bourla; For the 3rd time, EU Com­mis­sion could ex­tend ex­port scheme

4 years ago

The coro­n­avirus vac­cine that the world for­got could still help save it

4 years ago
In Focus

Covid-19 roundup: SAB's an­ti­body treat­ments move to PhI­II; Af­ter long jour­ney, No­vavax sub­mits vac­cine to WHO for re­view

4 years ago

Covid-19 roundup: BAR­DA pumps $60M more in­to SAB treat­ment; EMA to de­cide on boost­ers next month

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Bharat Biotech turns to oth­er pro­duc­ers to up sup­ply; Brazil, Ar­genti­na land mR­NA re­gion­al hubs

4 years ago
Manufacturing

Mitch Mc­Connell, top Re­pub­li­cans ques­tion Biden on get­ting ahead of FDA on Covid-19 boost­ers

4 years ago
FDA+

FDA au­tho­rizes Pfiz­er's vac­cine boost­er for se­niors, those at high risk for se­vere Covid-19

4 years ago

Fi­nal analy­sis of US-fund­ed Mod­er­na Covid vac­cine tri­al shows 98% ef­fi­ca­cy against se­vere dis­ease

4 years ago

Covid-19 roundup: Pfiz­er tees up 500M vac­cine dos­es for do­na­tion in ex­pand­ed US pact; Ear­ly remde­sivir helps stave off hos­pi­tal­iza­tions — study

4 years ago

With world still in sore need of dos­es, Clover says its Covid-19 vac­cine is 67% ef­fec­tive in Phase III

4 years ago
R&D

Covid-19 roundup: J&J boost­er shot da­ta show promise; CD­C's ACIP meet­ing this week to dis­cuss Pfiz­er boost­ers

4 years ago

Chaot­ic ad­comm sees Pfiz­er/BioN­Tech boost­ers re­ject­ed for gen­er­al pop­u­la­tion, but rec­om­mend­ed for old­er and high-risk pop­u­la­tions

4 years ago

Eu­ro­pean study finds that Gilead­'s Covid-19 an­tivi­ral remde­sivir shows no clin­i­cal ben­e­fit

4 years ago

Covid-19 roundup: FDA re­veals boost­er ad­comm ques­tion; Eli Lil­ly's an­ti­body cock­tail cleared for pre­ven­tion

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Kenya will add man­u­fac­tur­ing plant, up vac­ci­na­tion sites; South Ko­rea left wait­ing on Rus­sia vac­cine ex­ports

4 years ago
Manufacturing

At­tempt­ing to ride boost­er ad­comm coat­tails, Mod­er­na says its Covid-19 shot is bet­ter than Pfiz­er/BioN­Tech

4 years ago

Surg­ing US de­mand trig­gers new $2.9B pur­chase of Re­gen­eron's Covid-19 an­ti­bod­ies

4 years ago

Covid-19 roundup: Gilead touts pre­clin­i­cal promise for oral remde­sivir; Roche pre­pares for virus to be­come en­dem­ic

4 years ago

Covid-19 roundup: Cure­Vac backs out of man­u­fac­tur­ing con­tracts as de­mand dwin­dles; De­spite PhII/III flop, biotech keeps look­ing for sil­ver lin­ing

4 years ago

Da­ta do not sup­port wide­spread Covid vac­cine boost­ers right now, out­go­ing FDA lead­ers write in the Lancet

4 years ago
FDA+

Covid-19 roundup: UK pulls out of bil­lion-dol­lar vac­cine sup­ply deal as na­tion em­braces mix-and-match boost­er ap­proach

4 years ago

Covid-19 roundup: BioN­Tech pre­pares for vac­cine launch in 5- to 11-year-olds; Sino­vac weighs vac­cine pro­duc­tion site in South Africa — re­port

4 years ago
First page Previous page 20212223242526 Next page Last page
A service from the Financial Times